Skip to main content Accessibility help
×
Home

Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization

  • G. S. Turner (a1), K. G. Nicholson (a2), D. A. J. Tyrrell (a2) and F. Y. Aoki (a3)

Summary

The antibody responses of 194 volunteers were studied for up to 3 years after primary immunization with one, two or three doses of human diploid cell rabies vaccine, administered either in 0·1 ml volumes intradermally (i.d.) or as 1·0 ml intramuscularly (i.m.). Sero-conversion occurred in 95% of subjects after the first injection and in 100% after the second. The highest titres and most durable antibody responses were induced by three injections of vaccine.

Booster doses were administered either by the subcutaneous (s.c.) or i.d. route, after 6, 12 or 24 months to randomly grouped volunteers; these induced responses ≥ 5·0 i.u. per ml in 95% of subjects. The responses were rapid and were neither influenced by the primary regimen nor by the timing and route of the booster dose.

Antibody titres after i.d. immunization were only two-fold lower than those induced by the larger volume of vaccine. The findings suggest that the i.d. route is both effective and economic.

    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization
      Available formats
      ×

Copyright

References

Hide All
Ajjan, N., Soulebot, J. P., Triau, R.& Biron, G. (1980). Intradermal immunization with rabies vaccine. Journal of the American Medical Association 244, 25282531.
Anderson, L. J., Sikes, R. K., Langkop, L. W., Mann, J. M., Smith, J. S., Winkler, W. G. & Deitch, M. W. (1980). Post-exposure trial of a human diploid cell strain rabies vaccine. Journal of Infectious Diseases 142, 133138.
Aoki, F. Y., Tyrrell, D. A. J., Hill, L. E. & Turner, G. S. (1975). Immunogenicity and acceptability of a human diploid cell culture rabies vaccine in volunteers. Lancet i, 660662.
Atanasiu, P. (1973). Quantitative assay and potency test of antirabies serum and immunoglobulin. In Laboratory Techniques in Rabies, 3rd ed. (ed. Kaplan, M. M. and Koprowski, H.). World Health Organization Monograph series, no. 23, pp. 314318. Geneva: World Health Organization.
Bahmanyar, M., Fayaz, A., Nour-Salehi, S., Mohammadi, M. & Koprowski, H. (1976). Successful protection of humans exposed to rabies infection. Post-exposure treatment with the new human diploid cell rabies vaccine and rabies serum. Journal of the American Medical Association 236, 27512754.
Boe, E. & Nyland, H. (1980). Guillain-Barre syndrome after vaccination with human diploid cell rabies vaccine. Scandinavian Journal of Infectious Diseases 12, 231232.
Cox, J. H. & Schneider, L. G. (1976). Prophylactic immunization of humans against rabies by intradermal inoculations of human diploid cell culture vaccine. Journal of Clinical Microbiology 3, 96101.
Furlong, J. & Lea, G. (1980). Rabies prophylaxis simplified. Lancet i, 1311.
Kleitman, W., Schottle, A., Klietmann, B. & Cox, I. (1981). In Cell culture rabies vaccines and their protective effect in man (ed. Kuwert, E. K., Wiktor, T. J. & Koprowski, H.), pp. 330337. Geneva: International Green Cross.
Kuwert, E. K., Marcus, I. & Hoher, P. G. (1976). Neutralizing and complement-fixing antibody responses in pre- and post-exposure vaccinees to a rabies vaccine produced in human diploid cells. Journal of Biological Standardization 4, 244262.
Lorenz, R. J. & Bögel, K. (1973). Methods of calculation: the Spearman-Kärber method. In Laboratory Techniques in Rabies, 3rd ed. (ed. Kaplan, M. M. & Koprowski, H.), World Health Organization Monograph series no. 23, pp. 321329. Geneva: World Health Organization.
Miller, A. & Nathanson, N. (1977). Rabies: Recent advances in pathogenesis and control. Neurology 6, 511519.
Morbidity and Mortality Weekly Report (1977). Rabies in a laboratory worker, New York. 26, 183184.
Morbidity and Mortality Weekly Report (1981 a . Use of human diploid cell vaccine for post-exposure rabies treatment, Canada. 30 (22), 266267.
Morbidity and Mortality Weekly Report (1981 b). Supplementary statement on Rabies Vaccine and Serologic testing 30 (42). 535536.
Nicholson, K. G. & Prestage, H. (1982). Enzyme linked immunosorbent assay: a rapid reproducible test for the measurement of rabies antibody. Journal of Medical Virology 9, 4349.
Nicholson, K. G., Turner, G. S. & Aoki, F. Y. (1978). Immunization with a human diploid cell strain of rabies virus vaccine. Two year results. Journal of Infections Diseases 137, 783788.
Nicholson, K. G. & Turner, G. S. (1978). Studies with human diploid cell strain rabies vaccine and human antirahies immunoglobulin in man. Developments in Biological Standardization 40, 115120.
Nicholson, K. G., Cole, P. J., Turner, G. S. & Harrison, P. (1979). Immune responses of humans to a human diploid cell strain of rabies virus vaccine: Lymphocyte transformation. production of virus neutralizing antibody, and induction of interferon. Journal of Infectious Diseases 140. 176182.
Plotkin, S. A. & Wiktor, T. (1978). Rabies vaccination. Annual Reviews of Medicine 29, 583591.
Rosanoff, E. & Tint, H. (1979). Responses to human diploid cell rabies vaccine: neutralizing antibody responses of vaccinees receiving booster doses of human diploid cell rabies vaccine. American Journal of Epidemiology 110, 322327.
Seligman, E. B. (1973). The NIH test for potency. In Laboratory Techniques in Rabies, 3rd ed. (ed Kaplan, M. M. & Koprowski, H.). World Health Organization Monograph series no. 23, pp. 279286. Geneva: World Health Organization.
Simona, R., Keller, H., Spengler, G., Gerber, H., Weiss, M. & Steck, F. (1979). Revakzination gegen Lyssa beim Menschen: Wirksamkeit verechiedener Boosterschemata. Schweizerische Medizinische Wochenschrift 109, 17021708.
Turner, G. S. (1977). An assessment of the current position of rabies vaccination in man. In Recent Advances in Clinical Virology (ed. Waterson, A. P.). pp. 7992. London. Churchill Livingstone.
Turner, G. S., Aoki, F. Y., Nicholson, K. G.Tyrrell, D. A. J. & Hill, L. E. (1976). Human diploid cell strain rabies vaccine. Rapid prophylactic immunization of volunteers with small doses. Lancet i, 13791381.
Wiktor, T. J. & Koprowski, H. (1965). Successful immunisation of primates with rabies vaccine prepared in human diploid cells. Proceedings of the Society for experimental Biology & Medicine 118, 10691073.
World Health Organization Expert Committee on Rabies. Third Report (1957). World Health Organization Technical Report Series, no. 121.
World Health Organization Expert Committee on Rabies. Sixth Report (1973). World Health Organization Technical Report Series no. 523.
WHO/IABS (1978). Joint Symposium on the Standardization of rabies vaccines for human use produced in Tissue Culture (Rabies III) (ed. Hennessen, W. & Regamey, R. H.. Developments in Biological Standardization 40. pp. 2934. 79–139. 159–168. Basel: S. Karger.

Evaluation of a human diploid cell strain rabies vaccine: final report of a three year study of pre-exposure immunization

  • G. S. Turner (a1), K. G. Nicholson (a2), D. A. J. Tyrrell (a2) and F. Y. Aoki (a3)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed